Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-21-005355
Filing Date
2021-11-22
Accepted
2021-11-22 09:07:26
Documents
1
Period of Report
2021-11-17

Document Format Files

Seq Description Document Type Size
1 form4-11222021_061119.html 4  
1 form4-11222021_061119.xml 4 5860
  Complete submission text file 0001415889-21-005355.txt   7241
Mailing Address C/O INVESTOR GROWTH CAPITAL, INC. 630 FIFTH AVENUE, SUITE 1965 NEW YORK NY 10011
Business Address
LaBelle Curt H (Reporting) CIK: 0001396235 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38365 | Film No.: 211430353

Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Issuer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations